Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Guochun Lou
Institutions:
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
Observed institutions:
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
ORCID:
0000-0003-4590-7776
Observed ORCID:
0000-0003-4590-7776
OpenAlex ID:
A5006457357
Quadruple therapy with vonoprazan 20 mg daily as a first‐line treatment for Helicobacter pylori infection: A single‐center, open‐label, noninferiority, randomized controlled trial
2022
·
Lifen Lu
, Yujing Wang
, et al.
·
Helicobacter
·
63
PDF
MFAP2, upregulated by m1A methylation, promotes colorectal cancer invasiveness via CLK3
2022
·
Meng Xue
, Shuyi Mi
, et al.
·
Cancer Medicine
·
44
PDF
Is Tailored Bismuth Quadruple Therapies (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First‐Line Helicobacter pylori Eradication Treatment More Effective? A Three‐Arm, Multicenter Randomized Clinical Trial
2025
·
Zhengchen Yu
, Xiaochen Liu
, et al.
·
Helicobacter
·
12
PDF
Effectiveness and safety of a newly designed self-assembling gel in the treatment of endoscopic submucosal dissection-induced gastric ulcer: A multicenter randomized controlled trial
2022
·
Meng Li
, Xiaoliang Jin
, et al.
·
Frontiers in Pharmacology
·
6
Two-sample Mendelian randomization analysis of the relationship between periodontitis and risk of upper gastrointestinal cancers
2024
·
Shuyi Mi
, Shangwen Cai
, et al.
·
Postgraduate Medical Journal
·
3
PDF
Histological Helicobacter pylori Density Might Not be Associated With the Severity of Neutrophilic Inflammatory Activity
2026
·
Guochun Lou
, Zhengchen Yu
, et al.
·
DEN Open
Authors' Reply to the Letter on “Is Tailored Bismuth Quadruple Therapy (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First‐Line Helicobacter pylori Eradication Treatment More Effective? A Three‐Arm, Multicenter Randomized Clinical Trial”
2025
·
Zhengchen Yu
, Wenjuan Shen
, et al.
·
Helicobacter
PDF
m1A-regulated DIAPH3 promotes the invasiveness of colorectal cancer via stabilization of KRT19
2023
·
Shuyi Mi
, Guochun Lou
, et al.
·
Research Square
PDF
Efficacy of quadruple therapy with clarithromycin based on faecal molecular antimicrobial susceptibility tests as first-line treatment for Helicobacter pylori infection: a protocol of a single-centre, single-blind, randomised clinical trial in China
2023
·
Yaoyi Wu
, Yujing Wang
, et al.
·
BMJ Open
PDF
Show more works
View as search
Works count:
9
Citation count:
128
H-index:
4
I10-index:
3
Year
Topic
Type